Hochschulschrift
Tissue kallikrein-related peptidases as novel biomarkers in cancer : cellular analysis of expression, epigenetic regulation and relation to course of the disease
- Weitere Titel
-
Gewebekallikreine (Kallikrein-related peptidases) als neue Krebsbiomarker: Zelluläre Analyse der Expression, epigenetische Regulation und Zusammenhang mit dem Verlauf der Krebserkrankung
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Diss., 2012
- Klassifikation
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2012
- Urheber
-
Gkazepis, Apostolos
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bvb:91-diss-20110914-1081402-1-7
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Gkazepis, Apostolos
- Kessler, Horst
- Schmitt, Manfred
- Universitätsbibliothek der TU München
Entstanden
- 2012
Ähnliche Objekte (12)
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Epigenetic mechanisms in cellular reprogramming
Epigenetic biomarkers to track differentiation of pluripotent stem cells
Evaluation of Epigenetic Biomarkers in Primary and Iatrogenic Immune Deficiencies
Epigenetic and redox biomarkers : Novel insights from the MARK-AGE study
Kallikrein (Padutin)
Novel epigenetic biomarkers for diagnosis, prognosis and response prediction in colorectal cancer
Optimizing epigenetic therapies of hematological malignancies : identification of novel epigenetic biomarkers and mechanistic study of 5-aza-2'-deoxycytidine
Role of epigenetic biomarkers and IDH1 mutation in anticancer drug resistance of high‐grade gliomas
Dissecting cellular states and cell state transitions through integrative analysis of epigenetic dynamics
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer
Epigenetic biomarkers - selection of small cell-type-specific DNA methylation signatures for deconvolution of human tissues
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Epigenetic mechanisms in cellular reprogramming
Epigenetic biomarkers to track differentiation of pluripotent stem cells
Evaluation of Epigenetic Biomarkers in Primary and Iatrogenic Immune Deficiencies
Epigenetic and redox biomarkers : Novel insights from the MARK-AGE study
Kallikrein (Padutin)
Novel epigenetic biomarkers for diagnosis, prognosis and response prediction in colorectal cancer
Optimizing epigenetic therapies of hematological malignancies : identification of novel epigenetic biomarkers and mechanistic study of 5-aza-2'-deoxycytidine
Role of epigenetic biomarkers and IDH1 mutation in anticancer drug resistance of high‐grade gliomas
Dissecting cellular states and cell state transitions through integrative analysis of epigenetic dynamics
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer
Epigenetic biomarkers - selection of small cell-type-specific DNA methylation signatures for deconvolution of human tissues
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Epigenetic mechanisms in cellular reprogramming
Epigenetic biomarkers to track differentiation of pluripotent stem cells
Evaluation of Epigenetic Biomarkers in Primary and Iatrogenic Immune Deficiencies
Epigenetic and redox biomarkers : Novel insights from the MARK-AGE study
Kallikrein (Padutin)
Novel epigenetic biomarkers for diagnosis, prognosis and response prediction in colorectal cancer
Optimizing epigenetic therapies of hematological malignancies : identification of novel epigenetic biomarkers and mechanistic study of 5-aza-2'-deoxycytidine
Role of epigenetic biomarkers and IDH1 mutation in anticancer drug resistance of high‐grade gliomas
Dissecting cellular states and cell state transitions through integrative analysis of epigenetic dynamics
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer